KURA

Kura Oncology, Inc.

SEC CIK 1422143
$9.05 +12.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$154.8K
4 open-market
Net insider flow
−$154.8K
Net selling
Filings shown
65
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at KURA have sold a net $154.8K of stock (0 open-market buys vs 4 sells).

Largest recent trade: Wilson Troy Edward sold $3.63M of KURA, trimming their stake 100%.

Most active filer: Wilson Troy Edward, with 24 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for KURA, newest first
View on SEC EDGAR ↗
KURA
Sell Powl Brian T. · Chief Commercial Officer · Open-market sale · filed 3w ago ΔOwn −5.4%

Powl Brian T. sold $110K of KURA, trimming their stake 5%.

−$110K
10,000 sh @ $11
KURA
Sell Powl Brian T. · Chief Commercial Officer · Open-market sale · filed 3w ago ΔOwn −0.2%

Powl Brian T. sold $3.1K of KURA.

−$3.1K
339 sh @ $9
KURA
Sell FORD KATHLEEN · Chief Operating Officer · Open-market sale · filed 3w ago ΔOwn −1.4%

Ford Kathleen sold $20.5K of KURA, trimming their stake 1%.

−$20.5K
2,257 sh @ $9
KURA
Sell Bair Teresa Brophy · Chief Legal Officer · Open-market sale · filed 3w ago ΔOwn −1.0%

Bair Teresa Brophy sold $21.2K of KURA, trimming their stake 1%.

−$21.2K
2,256 sh @ $9
Advertisement
KURA
Sell Powl Brian T. · Chief Commercial Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −2.6%

Powl Brian T. sold $41K of KURA, trimming their stake 3%.

−$41K
4,842 sh @ $8
KURA
Sell Powl Brian T. · Chief Commercial Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −0.9%

Powl Brian T. sold $13.3K of KURA, trimming their stake 1%.

−$13.3K
1,572 sh @ $8
KURA
Sell FORD KATHLEEN · Chief Operating Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −1.2%

Ford Kathleen sold $15.3K of KURA, trimming their stake 1%.

−$15.3K
1,813 sh @ $8
KURA
Sell Leoni Mollie · Chief Medical Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −1.3%

Leoni Mollie sold $30.9K of KURA, trimming their stake 1%.

−$30.9K
3,655 sh @ $8
KURA
Sell Leoni Mollie · Chief Medical Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −0.8%

Leoni Mollie sold $18.9K of KURA, trimming their stake 1%.

−$18.9K
2,233 sh @ $8
KURA
Sell Leoni Mollie · Chief Medical Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −0.4%

Leoni Mollie sold $8K of KURA.

−$8K
951 sh @ $8
KURA
Sell Leoni Mollie · Chief Medical Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −0.5%

Leoni Mollie sold $11.3K of KURA.

−$11.3K
1,341 sh @ $8
KURA
Sell DOYLE THOMAS JAMES · SVP, Finance & Accounting · Open-market sale · filed Jan 27, 2026 ΔOwn −1.5%

Doyle Thomas James sold $18.8K of KURA, trimming their stake 2%.

−$18.8K
2,226 sh @ $8
KURA
Sell DOYLE THOMAS JAMES · SVP, Finance & Accounting · Open-market sale · filed Jan 27, 2026 ΔOwn −0.7%

Doyle Thomas James sold $9.4K of KURA, trimming their stake 1%.

−$9.4K
1,114 sh @ $8
KURA
Sell DOYLE THOMAS JAMES · SVP, Finance & Accounting · Open-market sale · filed Jan 27, 2026 ΔOwn −0.5%

Doyle Thomas James sold $5.9K of KURA.

−$5.9K
695 sh @ $8
KURA
Sell DOYLE THOMAS JAMES · SVP, Finance & Accounting · Open-market sale · filed Jan 27, 2026 ΔOwn −0.6%

Doyle Thomas James sold $7.5K of KURA, trimming their stake 1%.

−$7.5K
881 sh @ $8
KURA
Sell Burrows Francis · Chief Scientific Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −3.9%

Burrows Francis sold $11.1K of KURA, trimming their stake 4%.

−$11.1K
1,311 sh @ $8
KURA
Sell Bair Teresa Brophy · Chief Legal Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −1.7%

Bair Teresa Brophy sold $34.7K of KURA, trimming their stake 2%.

−$34.7K
4,096 sh @ $8
KURA
Sell Bair Teresa Brophy · Chief Legal Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −1.0%

Bair Teresa Brophy sold $19.8K of KURA, trimming their stake 1%.

−$19.8K
2,335 sh @ $8
KURA
Sell Bair Teresa Brophy · Chief Legal Officer · Open-market sale · filed Jan 27, 2026 ΔOwn −2.1%

Bair Teresa Brophy sold $40.4K of KURA, trimming their stake 2%.

−$40.4K
4,777 sh @ $8
KURA
Sell Leoni Mollie · Chief Medical Officer · Open-market sale · filed Nov 14, 2025 ΔOwn −6.4%

Leoni Mollie sold $173.1K of KURA, trimming their stake 6%.

−$173.1K
15,485 sh @ $11
KURA
Sell DOYLE THOMAS JAMES · SVP, Finance & Accounting · Open-market sale · filed Nov 14, 2025 ΔOwn −3.4%

Doyle Thomas James sold $50.7K of KURA, trimming their stake 3%.

−$50.7K
4,539 sh @ $11
KURA
Sell Leoni Mollie · Chief Medical Officer · Open-market sale · filed Sep 29, 2025 ΔOwn −7.2%

Leoni Mollie sold $110.1K of KURA, trimming their stake 7%.

−$110.1K
12,314 sh @ $9
KURA
Sell WILSON TROY EDWARD · Director, President and CEO · Open-market sale · filed Sep 29, 2025 ΔOwn −13%

Wilson Troy Edward sold $327.4K of KURA, trimming their stake 13%.

−$327.4K
36,615 sh @ $9
KURA
Sell DOYLE THOMAS JAMES · SVP, Finance & Accounting · Open-market sale · filed Sep 29, 2025 ΔOwn −4.0%

Doyle Thomas James sold $40.6K of KURA, trimming their stake 4%.

−$40.6K
4,541 sh @ $9
Advertisement

About KURA insider activity

This page tracks every recent Form 4 filed for Kura Oncology, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is KURA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Kura Oncology, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.